BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:45 PM
Apr 30, 2007
 |  BC Extra  |  Company News

EC approves Sebivo for HBV

The European Commission approved an MAA for Sebivo telbivudine from Idenix (IDIX) and Novartis (NVS; SWX:NOVN)...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >